Literature DB >> 18638721

A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects.

N W Dorsch1, M T King.   

Abstract

Delayed ischaemia due to cerebral 'vasospasm' is a significant cause of morbidity and mortality after aneurysm haemorrhage. In a literature review more than 30 000 cases were found where vasospasm after subarachnoid haemorrhage (SAH) was discussed. The incidence of angiographic vasospasm was 43.3% overall, and 67.3% where angiography was done at a time of maximum expected spasm. Symptomatic vasospasm or delayed ischaemic deficit (DID) occurred in 32.5%. There was no difference in incidence and time course between preoperative and postoperative cases. 30% of those with DID died, and permanent neurological deficits occurred in 34%. A fatal outcome was much more likely in the presence of vasospasm, and a satisfactory outcome one third less likely. Vasospasm is thus the cause of death in about 10%, and of disability in slightly more cases of aneurysmal SAH. The extent of the problem has not changed significantly over three decades.

Entities:  

Year:  1994        PMID: 18638721     DOI: 10.1016/0967-5868(94)90005-1

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  66 in total

Review 1.  Neurovascular events after subarachnoid hemorrhage: focusing on subcellular organelles.

Authors:  Sheng Chen; Haijian Wu; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2015

2.  Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist.

Authors:  Paul L M van Giersbergen; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2006-04-25       Impact factor: 2.953

3.  An association between hypernatremia, adverse cardiac outcomes and mortality in patients with subarachnoid hemorrhage.

Authors:  Christos Lazaridis; Romergryko Geocadin; Marek Mirski
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 4.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 5.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

6.  Continuous EEG Monitoring for Early Detection of Delayed Cerebral Ischemia in Subarachnoid Hemorrhage: A Pilot Study.

Authors:  M L Rots; M J A M van Putten; C W E Hoedemaekers; J Horn
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

Review 7.  Cerebral Microdialysis in Neurocritical Care.

Authors:  Ting Zhou; Atul Kalanuria
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

8.  Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis.

Authors:  Mohammed Sabri; Ayako Kawashima; Jinglu Ai; R Loch Macdonald
Journal:  Brain Res       Date:  2008-08-23       Impact factor: 3.252

9.  Vasospasm Risk in Surgical ICU Patients With Grade I Subarachnoid Hemorrhage.

Authors:  George Lominadze; Samantha Lessen; Adam Keene
Journal:  Neurohospitalist       Date:  2016-01

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.